Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Dec 2019 07:00 AM
RNS
Agreement with KSQ Therapeutics
21 Nov 2019 07:00 AM
RNS
Vor Biopharma Clinical and Commercial License
14 Nov 2019 07:00 AM
RNS
Presentation at Jefferies Healthcare Conference
07 Nov 2019 07:00 AM
RNS
MaxCyte to Present at BIO-Europe 2019
01 Nov 2019 01:04 PM
RNS
Result of AGM
24 Oct 2019 07:00 AM
RNS
MaxCyte Advances Phase I Clinical Trial
23 Oct 2019 07:01 AM
RNS
Presentations at Cell & Gene Therapy Congress
08 Oct 2019 07:00 AM
RNS
Notification of AGM and Audit Declaration
07 Oct 2019 07:00 AM
RNS
Editas Clinical and Commercial License Agreement
30 Sep 2019 07:00 AM
RNS
Updates on CARMA Platform at Upcoming Meetings
18 Sep 2019 07:00 AM
RNS
Results for the Six Months ended 30 June 2019
09 Sep 2019 07:00 AM
RNS
Presentation at ICLE 2019
14 Aug 2019 07:00 AM
RNS
Notice of Results
17 Jul 2019 07:00 AM
RNS
Trading Update
11 Jul 2019 07:00 AM
RNS
MaxCyte to Host Capital Markets Day Today
05 Jul 2019 04:42 PM
RNS
Second Price Monitoring Extn
05 Jul 2019 04:36 PM
RNS
Price Monitoring Extension
19 Jun 2019 07:00 AM
RNS
Annual Report
12 Jun 2019 07:00 AM
RNS
Appointment of Joint Corporate Broker
29 May 2019 07:00 AM
RNS
Save the Date: Capital Markets Day
08 May 2019 04:41 PM
RNS
Second Price Monitoring Extn
08 May 2019 04:36 PM
RNS
Price Monitoring Extension
08 May 2019 07:00 AM
RNS
Phase I Clinical Trial of MCY-M11 Progressed
01 May 2019 07:00 AM
RNS
ASGCT Presentation on First CARMA Drug Candidate
24 Apr 2019 07:00 AM
RNS
Final Results for Year Ended 31 December 2018
08 Apr 2019 07:00 AM
RNS
Launch of ExPERTT Instrument Family
26 Mar 2019 07:00 AM
RNS
Notice of Full Year Results
19 Mar 2019 05:05 PM
RNS
Director Dealings
05 Mar 2019 07:00 AM
RNS
Grant of Options
01 Mar 2019 07:00 AM
RNS
Clinical & Commercial Agreement with Kite
26 Feb 2019 05:32 PM
RNS
Result of Special Meeting and Issue of Equity
05 Feb 2019 04:32 PM
RNS
Results of Placing
05 Feb 2019 07:00 AM
RNS
Proposed Placing to raise a minimum of £10 million
15 Jan 2019 07:00 AM
RNS
Trading Update
19 Dec 2018 07:00 AM
RNS
Change of Auditor
17 Dec 2018 06:06 PM
RNS
Director Dealings
21 Nov 2018 07:00 AM
RNS
Consolidation of Trading Lines
20 Nov 2018 07:00 AM
RNS
Block Admission Six Monthly Return/TVR
16 Nov 2018 07:00 AM
RNS
Webinar: non-viral cell engineering
14 Nov 2018 07:00 AM
RNS
Clinical and Commercial License Agreement
12 Nov 2018 07:00 AM
RNS
MaxCyte Announces Research Agreement with Kite
09 Nov 2018 07:00 AM
RNS
Expansion of CRISPR Commercial License Agreement
31 Oct 2018 04:25 PM
RNS
Result of AGM
10 Oct 2018 07:00 AM
RNS
Dosing Begins in First Clinical Trial of MCY-M11
08 Oct 2018 07:00 AM
RNS
Notice of AGM
24 Sep 2018 07:00 AM
RNS
Results for the Half Year ended 30 June 2018
10 Sep 2018 07:00 AM
RNS
Grant of Options
03 Sep 2018 07:00 AM
RNS
Notice of Half Year Results
26 Jul 2018 05:33 PM
RNS
Director/PDMR Shareholding
16 Jul 2018 07:00 AM
RNS
FDA IND Clearance for First Clinical Programme
UK 100

Latest directors dealings